Drug-drug interactions and the cytochrome P450 system: An update

Pediatric Emergency Care

Volumn 13, Issue 5, 1997, Pages 350-353

  Shannon, Michael ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b Massachusetts Poison Control System   (United States)

Author keywords

Cytochrome P450 system; Drug drug interactions; Medication allergies; Pharmacogenetics

Indexed keywords

ALCOHOL; ANTIHISTAMINIC AGENT; ASTEMIZOLE; CAFFEINE; CISAPRIDE; CLARITHROMYCIN; CYCLOPHOSPHAMIDE; CYTOCHROME P450; DEXTROMETHORPHAN; DIAZEPAM; DICLOFENAC; ERYTHROMYCIN; FLUCONAZOLE; IBUPROFEN; KETOCONAZOLE; LORATADINE; MACROLIDE; NAPROXEN; PARACETAMOL; PAROXETINE; PHENOBARBITAL; PHENYTOIN; SEROTONIN UPTAKE INHIBITOR; TERFENADINE; THEOPHYLLINE; TOLBUTAMIDE; TRICYCLIC ANTIDEPRESSANT AGENT; TROLEANDOMYCIN; UNINDEXED DRUG; WARFARIN;

CARDIOTOXICITY; CHILD; CHILD HEALTH CARE; DRUG ALCOHOL INTERACTION; DRUG METABOLISM; EMERGENCY MEDICINE; ENZYME INDUCTION; ENZYME INHIBITION; GENETIC POLYMORPHISM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER TOXICITY; LONG QT SYNDROME; NOMENCLATURE; ORAL DRUG ADMINISTRATION; PHARMACODYNAMICS; PHARMACOGENETICS; REVIEW;

CYTOCHROME P-450 ENZYME SYSTEM; DRUG INTERACTIONS; HUMANS; POLYMORPHISM, GENETIC; TERMINOLOGY;

EID: 0030730077     PISSN: 07495161     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006565-199710000-00015     Document Type: Review

References (31)

1. Watkins PB. Drug metabolism by cytochtomes P450 in the liver and small bowel. Gastroenterol Clin North Am 1992;21:511-526.
2. Paine AJ. Heterogeneity of cytochrome P450 and its lexicological significance. Hum Exp Toxicol 1995; 14:1-7.
3. Pham Z, Anderson P. Cytochrome P450 in drug metabolism and interactions. Discourse (UCSD Medical Center) 1996;18:1-3.
4. Honig P, Wortham D, Zamani K, Conner D, Mullin J, Cantilena L. Terfenadine-ketoconazole interaction: Pharmacokinetic and electrocardiographic consequences. JAMA 1993;269:1513-1518.
5. Fuhr U, et al. Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man. Br J Clin Pharmacol 1993;35:431-436.
6. O'Dell J, Zetterman R, Burnett D. Centrilobular hepatic fibrosis fol-lowing acetaminophen-induced hepatic necrosis in an alcoholic. JAMA 1986;255:2636-2637.
7. Seeff L, Cuccherini B, Zimmerman H, et al. Acetaminophen hepatotoxicity in alcoholics-A therapeutic misadventure. Ann Intern Med 1986;104:39904.
8. Leist M, Gluskin L, Payne J. Enhanced toxicity of acetaminophen in alcoholics: report of three cases. J Clin Gastroenterol 1985;7:55-59.
9. Whitcomb D, Block G. Association of Acetaminophen Hepatotoxicity with fasting and ethanol use. JAMA 1994;272:1845-1850.
10. Floren C-H, Thesleff P, Nilsson A. Severe liver damage caused by therapeutic doses of acetaminophen. Acta Med Scand 1987;222:285-288.
11. Black M, Raucy J. Acetaminophen, alcohol, and cytochrome P-450. Ann Intern Med 1986;104:427-429.
12. Pirmohamed M, Kitteringham NR, Park BK. The role of active metabolites in drug toxicity. Drug Safety 1994;! 1:114-144.
13. Hcndeles L, Jenkins J, Temple R. Revised PDA labeling guideline for theophylline oral dosage forms. Pharmacotherapy 1995;15:409-427.
14. Lee B, Benowitz N, Jacob P. Cigarette abstinence, nicotine gum, and theophylline disposition. Ann Intern Med 1987;106:553.
15. Marquis J-F, SG, Spence J, Brownstone Y, et al. Phenytoin-theo. phylline interaction. N Engl J Med 1982;307:1189-1190.
16. Committee on Drugs, American Academy of Pediatrics. Precautions concerning the use of theophylline. Pediatrics 1992;89:781-782.
17. Powell J, Rogers J, Wargin W, et al. Inhibition of theophylline clearance by cimetidine but not ranitidine. Arch Intern Med 1984; 144:484-486.
18. Cremer K, Secor J. Spttg K. The effect of route of administration on the cimetidine-theophylline drug interaction. J Clin Pharmacol 1989;29: 451-456.
19. Hendeles L, Massanari M, Weinberger M. Theophylline. In: Evans W, Schentag J, Jusko W, eds. Clinical pharmacokinetics. Spokane, WA: Applied Therapeutics, Inc, 1986;! 105-1172.
20. LaForce C, Miller M, Chai H. Effect of erythromycin on theophylline clearance in asthmatic children. J Pediatr 1981;99:153-156.
21. Rieder M, Spino M. The theophylline-erythromycin interaction. J Asthma 1988;25:195-204.
22. Richards W, Church J, Brent D. Theophylline-associated seizures in children. Ann Allergy 1985;54:276-279.
23. Parish R, Haulman N, Bums R. Interaction of theophylline with erythromycin base in a patient with seizure activity. Pediatrics 1983;72: 828-830.
24. Hildebrandt R, Gundert-Remy U, Moller H, et al. Lack of clinically important interaction between erythromycin and theophylline. Eur J Clin Pharmacol 1984:26:485-189.
25. Simons F, Simons K. The pharmacology and use of HI-receptor-antagonists drugs. New Engl J Med 1994;330:1663. .
26. Woosley R, Chen Y, Freiman J, et al. Mechanism of the cardiotoxic actions of terfenadine. JAMA 1993;269:1532-1536.
27. Monohan B, Ferguson C, Killeavy E, et al. Torsades de pointes occurring in association with terfenadine use. JAMA 1990;264:2788-2790.
28. Harris S, Hilligoss D, Colangelo P, et al. Azithromycin and terfenadine: Lack of drug interaction. Clin Pharmacol Ther 1995:58:310-315.
29. Janssen Pharmaceuticals. Reported labeling changes. October 14, 1995.
30. Harvey A, Burke M. Comment on the serotonin syndrome associated with paroxetine, an over-the-counter cold remedy, and vascular disease. Am J Emerg Med 1995:13:605-606.
31. Skop B, Finkelstein J, Mareth T, et al. The serotonin syndrome associated with paroxetine, an over-the-counter cold remedy, and vascular disease. Am J Emerg Med 1994:12:642-644.